Form 4: Docusign CFO Sells Shares Under 10b5-1 Plan

Docusign's Chief Financial Officer, Blake Jeffrey Grayson, has sold a significant number of company shares through a pre-arranged trading plan.

Summary

• Blake Jeffrey Grayson, Chief Financial Officer of Docusign, Inc., executed transactions involving the sale of Docusign common stock on July 1, 2026.
• These sales were conducted under a Rule 10b5-1 trading plan, which is designed to comply with affirmative defense conditions for insider trading.
• A total of 14,400 shares were sold at prices ranging from $44.95 to $45.90, resulting in a direct beneficial ownership of 142,029 shares.
• Additionally, 600 shares were sold at prices ranging from $45.95 to $46.04, leaving 141,429 shares in direct beneficial ownership.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the significant sale of shares by the CFO, despite the transaction being executed under a pre-arranged plan.

Negatives

• The Chief Financial Officer sold a substantial number of shares, which could be perceived negatively by the market.
• The total value of shares sold is approximately $660,000 based on the reported price ranges.

Risks

• Potential negative market perception due to insider selling, even if conducted under a 10b5-1 plan.
• The sales may indicate a lack of confidence in near-term stock price appreciation by a key executive.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it solely reports on past transactions.

Industry Context

StockSavvy.ai notes that insider selling, particularly by C-suite executives, is a common event. However, the execution of sales under a Rule 10b5-1 plan suggests a pre-determined strategy rather than a reaction to immediate non-public information. The volume of shares sold by the CFO will be a point of observation for investors.

Stakeholder Impact

• Shareholders may view the CFO's sale of stock negatively, potentially impacting short-term share price sentiment.
• Employees with stock options or grants may be concerned about the perceived confidence of leadership in the company's stock performance.

Key Dates

Recommendation

While the sale of shares by a key executive can be a negative signal, the transaction was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on current non-public information. This filing alone does not provide sufficient information to warrant a strong buy or sell recommendation, suggesting a 'hold' position pending further company performance data.

Keywords

Docusign, DOCU, Form 4, Insider Trading, 10b5-1 Plan, Blake Jeffrey Grayson, CFO, Stock Sale, Beneficial Ownership